Diabetic Retinopathy

FA implant outperforms anti-VEGF in DR patients lost-to-follow-up

September 08, 2020

Results could provide a new preferred treatment paradigm for this population

Identifying biomarkers to predict diabetic retinopathy progression

September 01, 2020

Study explores correlations between functional and structural tests

AMD, DED most common retinal conditions in the United States

August 13, 2020

The number of patients with retinal diseases is steadily increasing in the United States, according to a retrospective study presented during ARVO 2020.

VISTA subanalysis: Macular RNP and clinical outcomes

August 11, 2020

Reductions in macular retinal nonperfusion after anti-VEGF treatment with aflibercept are correlated with improvements in BCVA and central retinal thickness in patients with DR/DME, according to a post-hoc analysis of the VISTA dataset, said Charles C. Wykoff, MD, PhD, during ARVO 2020.

ASRS 2020: Diabetic retinopathy progression in anti-VEGF versus FA implant

August 01, 2020

Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.

Study explores mental health issues in patients with diabetic retinopathy

August 01, 2020

Rates of anxiety and depression increased but were not necessarily tied to disease severity